Besides being a well-known m6A writer, ALKBH5 also collaborates with METTL14/IGF2BPs to suppress tumor cell glycolysis by negatively regulating the JMJD8/PKM2 signaling axis, thereby slowing down colorectal cancer progression. Here, METTL14 is linked to neoplasm.